A case of double‐negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab.

Autor: Tanaka, Hiroki, Yoshida, Soichiro, Aoyama, Satoru, Ikeda, Sadakatsu, Kunieda, Junko, Ohashi, Kenichi, Fukuda, Shohei, Waseda, Yuma, Tanaka, Hajime, Fujii, Yasuhisa
Zdroj: IJU Case Reports; Sep2024, Vol. 7 Issue 5, p395-398, 4p
Databáze: Complementary Index
Externí odkaz: